Precision Therapeutics’ Helomics Division Selected by AccuGenomics as Preferred Lab Partner for NIIMBL Grant

    NEXT STORY
    HIV Cure Program Patent Granted To American Gene Technologies
    PREV STORY
    Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors – Corrected Version
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Valneva Announces FDA Approval of IXIARO® Shelf Life Extension to 36 Months; New US Military RFP Issued

    author_avatar
    NASDAQ Market News

    AXIM® Biotechnologies Appoints Dr. Alim Seit-Nebi as Chief Technology Officer of Subsidiary Sapphire Biotech

    author_avatar
    NASDAQ Market News

    Gene Therapy Market to Reach US$ 5164.03 Million by 2026, Says TMR

    Gene Therapy Market: New Product Approvals and Commercialization to Boost MarketAlbany, NY, Nov. 08, ...

    author_avatar
    NASDAQ Market News